Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India
· Delayed Price · Currency is INR 1,251.80
-2.90 (-0.23%)
Jul 14, 2025, 3:29 PM IST
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 1.04 trillion as of July 14, 2025. Its market cap has increased by 2.91% in one year.
Market Cap
1.04T
Enterprise Value
1.03T
Revenue
325.54B
Ranking
n/a
PE Ratio
18.41
Stock Price
1,251.80
Market Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 1.04T, an increase of 4,855.89%. That is a compound annual growth rate of 16.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 1,043.49B | -9.77% |
| Dec 31, 2024 | 1,156.53B | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | 863.44B | 81.04% |
| Dec 31, 2019 | Pro | Pro |
| Dec 31, 2018 | Pro | Pro |
| Dec 29, 2017 | Pro | Pro |
| Dec 30, 2016 | Pro | Pro |
| Dec 31, 2015 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,011.69B |
| Divi's Laboratories | 1,814.48B |
| Cipla | 1,199.45B |
| Mankind Pharma | 1,064.14B |
| Apollo Hospitals Enterprise | 1,033.74B |
| Zydus Lifesciences | 985.71B |
| Aurobindo Pharma | 653.29B |
| Glenmark Pharmaceuticals | 615.51B |